1. Trang chủ
  2. » Tài Chính - Ngân Hàng

5 musculoskeletal high yield

330 68 0

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 330
Dung lượng 8,12 MB

Nội dung

Musculoskeletal and Connective Tissue Stephen Bagley, M.D Resident Physician, University of Pennsylvania MUSC1_1MS01- Musculoskeletal System: Dermatology Anatomy, physiology, and disease of: – – – – – Skin Muscles and ligaments Peripheral nerves Bones Connective tissue MUSC1_1MS01- Musculoskeletal and Connective Tissue Lecture - Dermatology MUSC1_1MS01- Skin layers from surface to base Epidermal layers: Basement membrane C – Stratum corneum L – Stratum lucidum G – Stratum granulosum S - Stratum spinosum Stratum basalis B – Stratum basalis Mnemonic: Californians Like Girls in String Bikinis Kaplan Pathology 2010: Figure 11-1 FA 2013: 378.1 • FA 2012: 404.1 • FA 2011: 370.1 ME 3e: 451 • ME 4e: 451 MUSC1_1- Skin layers from surface to base Epidermal layers: Basement membrane C – Stratum corneum • Top layer • Continuously sloughed off Stratum basalis • Composed of keratin filled anucleate cells • Calluses: stratum corneum hypertrophy Kaplan Pathology 2010: Figure 11-1 FA 2013: 378.1 • FA 2012: 404.1 • FA 2011: 370.1 ME 3e: 451 • ME 4e: 451 MUSC1_1- Skin layers from surface to base Epidermal layers: Basement membrane L – Stratum lucidum • This layer is only found in thick skin (e.g palms and soles) Stratum basalis Kaplan Pathology 2010: Figure 11-1 FA 2013: 378.1 • FA 2012: 404.1 • FA 2011: 370.1 ME 3e: 451 • ME 4e: 451 MUSC1_1- Skin layers from surface to base Epidermal layers: Basement membrane G – Stratum granulosum Stratum basalis Kaplan Pathology 2010: Figure 11-1 FA 2013: 378.1 • FA 2012: 404.1 • FA 2011: 370.1 ME 3e: 451 • ME 4e: 451 MUSC1_1- Skin layers from surface to base Epidermal layers: Basement membrane S - Stratum spinosum Stratum basalis Kaplan Pathology 2010: Figure 11-1 FA 2013: 378.1 • FA 2012: 404.1 • FA 2011: 370.1 ME 3e: 451 • ME 4e: 451 MUSC1_1- Skin layers from surface to base Epidermal layers: Basement membrane B – Stratum basalis • Home to stem cells Stratum basalis Kaplan Pathology 2010: Figure 11-1 FA 2013: 378.1 • FA 2012: 404.1 • FA 2011: 370.1 ME 3e: 451 • ME 4e: 451 MUSC1_1- Skin layers from surface to base Basement membrane: • Separates the epidermis from the dermis en:wp, commons.wikimedia.org Used with permission FA 2013: 378.1 • FA 2012: 404.1 • FA 2011: 370.1 ME 3e: 451 • ME 4e: 451 MUSC1_1- 10 Myositis Disorders • Characteristics: • Ongoing inflammation of the muscles • Labs: • ↑ Creatinine kinase levels FA 2013: 394.2 • FA 2012: 422.2 • FA 2011: 386.3 ME 3e: 450 • ME 4e: 450 MUSC6_4- Polymyositis • Characteristics: • Inflammation of multiple muscle groups • Progressive and symmetric • Proximal muscle groups affected the most (e.g hips and shoulders) • Etiology: • • CD8+ T-cell injury to myofibers Histology: • • Endomysial inflammation, within muscle fibers Labs: • ↑ Creatinine kinase levels Muscle biopsy on H&E showing endomysial inflammation Polymyositis HE.jpg, commons.wikimedia.org Used with permission FA 2013: 394.2 • FA 2012: 422.2 • FA 2011: 386.3 ME 3e: 450 • ME 4e: 450 MUSC6_4- Dermatomyositis • Characteristics: • Inflammation of multiple muscle groups • Proximal muscle groups affected the most (e.g hips and shoulders) • Histology: • • Perivascular (perimysial) inflammation, within muscle fibers Labs: • ↑ Creatinine kinase levels • ↑ Aldolase levels Perimysial inflammation Dermatomyositis – high mag.jpg, commons.wikimedia.org Used with permission FA 2013: 394.2 • FA 2012: 422.2 • FA 2011: 386.3 ME 3e: 450 • ME 4e: 450 MUSC6_4- Dermatomyositis: Signs and symptoms Signs/symptoms: • Heliotrope rash (periorbital) • “Shawl and face” rash • Gottron’s papules develop on the dorsal fingers, over joints • “Mechanic’s hands” (i.e callused hands) Other characteristics: • ↑ Risk of malignancy (e.g colon and ovarian cancer) • Antibodies: • ANA (sensitive yet non-specific) • Anti-Jo-1 (very specific) • Copyright Richard Usatine, M.D Used with permission • Copyright Richard Usatine, M.D Used with permission • Treatment: • Steroids to reduce inflammation Heliotrope rash FA 2013: 394.2 • FA 2012: 422.2 • FA 2011: 386.3 ME 3e: 450 • ME 4e: 450 MUSC6_4- Neuromuscular junction diseases Kaplan Pathology 2010 Figure 29.2 Neuromuscular Junction Physiology FA 2013: 394.3 • FA 2012: 422.3 • FA 2011: 386.4 ME 3e: 450 • ME 4e: 450 MUSC6_5- Myasthenia gravis • Etiology: • Antibodies against the post-synaptic acetylcholine receptors of the NMJ Bind to and inactivates the receptor • • Signs/symptoms: • • Muscle weakness that worsens with prolonged use Typically affects the facial muscles • Ptosis • Extraocular muscles • Double vision • • Respiratory muscle involvement Diagnostic tests: • Electromyography: repetitive nerve stimulation testing • • • Progressive decrease in action potential size of affected muscle groups Edrophonium (an achetylcholinesterase inhibitor) improves symptoms Other characteristics: • Associated with thymoma FA 2013: 394.3 • FA 2012: 422.3 • FA 2011: 386.4 ME 3e: 450 • ME 4e: 450 Kaplan Immunology-Microbiology 2010 Figure I-13-5 MUSC6_5- Lambert-Eaton syndrome • Etiology: • Antibodies against the presynaptic calcium channels of the neuromuscular junction Antibody mediated attack • • Decreased acetylcholine release with neuronal transmission Signs/symptoms: • • Proximal muscle weakness that improves with repeated use Other characteristics: • Associated with malignancy, occurring as a paraneoplastic syndrome (e.g small cell lung cancer) FA 2013: 394.3 • FA 2012: 422.3 • FA 2011: 386.4 ME 3e: 450 • ME 4e: 450 Kaplan Pathology 2010 Figure 29.2 MUSC6_5- Lambert-Eaton syndrome • Diagnostic tests: • Electromyography: repetitive nerve stimulation testing • Progressive increase in action potential size of affected muscle groups Antibody mediated attack • Edrophonium does not improve symptoms Kaplan Pathology 2010 Figure 29.2 FA 2013: 394.3 • FA 2012: 422.3 • FA 2011: 386.4 ME 3e: 450 • ME 4e: 450 MUSC6_5- Scleroderma (progressive systemic sclerosis – PSS) • Two types • Diffuse scleroderma • Excessive fibrosis and collagen deposition throughout the body • Rapidly progressive • Sites of involvement: • Skin involvement (thick and leathery) • Visceral organ involvement • Lungs involvement (interstitial lung fibrosis) is usually the cause of death • Etiology: • Anti Scl-70 antibodies against topoisomerase FA 2013: 395.1 • FA 2012: 423.1 • FA 2011: 387.1 ME 3e: 107, 264 • ME 4e: 107, 264 Perioral Scleroderma Involvement Copyright Richard Usatine, M.D Used with permission MUSC6_6- Scleroderma (progressive systemic sclerosis – PSS) • Two types Diffuse scleroderma: CREST syndrome: • Sites of involvement: • • • • • Calcinosis Raynaud’s phenomenon Esophageal dysmotility (associated with GERD) Sclerodactyly Telangiectasia • Limited skin involvement • More benign course • Etiology: • Telangiectasias fingers scleroderma Copyright Richard Usatine, M.D Used with permission Anti centromere antibodies FA 2013: 395.1 • FA 2012: 423.1 • FA 2011: 387.1 ME 3e: 107, 264 • ME 4e: 107, 264 MUSC6_6- Tumor Necrosis Factor Alpha (TNF-α) Inhibitor: • General characteristics: • A class of drugs that inhibit the affects of TNF-α • TNF-α is an important inflammatory mediator FA 2013: 406.2 • FA 2012: 432.1 • FA 2011: 393.1 ME 3e: 448 • ME 4e: 448 MUSC6_7- Etanercept • Mechanism: • Recombinant form of the human TNF receptor that binds TNF • Decreases the net effect of TNF-α • Clinical Use: • Rheumatoid arthritis • Psoriasis • Ankylosing spondylitis FA 2013: 406.2 • FA 2012: 432.1 • FA 2011: 393.1 ME 3e: 448 • ME 4e: 448 MUSC6_7- Infliximab • Mechanism: • Anti-TNF antibody • Decreases the net effect of TNF-α • Clinical use: • Crohn’s disease • Rheumatoid arthritis • Ankylosing spondylitis • Adverse effects: • Predisposition to infections • Particularly latent tuberculosis reactivation • It’s important to assess for signs of TB prior to initiating Infliximab FA 2013: 406.2 • FA 2012: 432.1 • FA 2011: 393.1 ME 3e: 448 • ME 4e: 448 MUSC6_7- Adalimumab • Mechanism: • Anti-TNF antibody • Decreases the net effect of TNF-α • Clinical use: • Rheumatoid arthritis • Psoriasis • Ankylosing spondylitis FA 2013: 406.2 • FA 2012: 432.1 • FA 2011: 393.1 ME 3e: 448 • ME 4e: 448 MUSC6_7- Musculoskeletal and Connective Tissue: Summary • Anatomy, physiology, and disease of: • Skin • Muscles and ligaments • Peripheral nerves • Bones • Connective tissue MUSC6_8- ... patients Copyright Richard Usatine, M.D Used with permission FA 2013: 3 95. 2 • FA 2012: 423.2 • FA 2011: 387.2 ME 3e: 157 • ME 4e: 157 MUSC1_2- Pustule Name Description Pustule Blister containing pus... Kaplan Pathology 2010: Figure 11-1 FA 2013: 378.1 • FA 2012: 404.1 • FA 2011: 370.1 ME 3e: 451 • ME 4e: 451 MUSC1_1- Skin layers from surface to base Epidermal layers: Basement membrane C – Stratum... Kaplan Pathology 2010: Figure 11-1 FA 2013: 378.1 • FA 2012: 404.1 • FA 2011: 370.1 ME 3e: 451 • ME 4e: 451 MUSC1_1- Skin layers from surface to base Epidermal layers: Basement membrane L – Stratum

Ngày đăng: 17/06/2019, 17:03

TÀI LIỆU CÙNG NGƯỜI DÙNG

  • Đang cập nhật ...

TÀI LIỆU LIÊN QUAN